---
title: "Metabolic Disease Reconfigures the Colorectal Cancer Ecosystem"
id: "pubmed-43043549"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43043549"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43043549/"
doi: "10.1007/s10555-026-10399-y"
published_at: "2026-11-17T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Metabolic Disease Reconfigures the Colorectal Cancer Ecosystem
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43043549
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43043549/)
- **DOI:** [10.1007/s10555-026-10399-y](https://doi.org/10.1007%2Fs10555-026-10399-y)
- **Published At:** 2026-11-17T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The author proposes that **metabolic disease**—notably **obesity** and **type 2 diabetes (T2D)**—alters the colonic environment in ways that change which neoplastic clones emerge and persist. - Metabolic dysfunction is framed as an "ecosystem engineer": it shifts nutrient supplies, adipose function, immunometabolic states, bile acid composition, and the **gut microbiota**, redistributing metabolic fitness across epithelial, immune, and microbial populations. - Investigators reported interactions among nutrient availability, adipose dysfunction, metabolic-epigenetic coupling, immunometabolic rewiring, microbial remodeling, and bile acid metabolism that together may create a self-reinforcing environment favoring metabolically adaptable tumor clones. - The review team observed that such host metabolic states could permit similar molecular tumors to exist in biologically distinct microenvironments and to respond differently to immune activity and therapy. - The author suggests integrating systemic metabolic parameters—including adiposity distribution, insulin resistance, glycemic control, circulating metabolites, and microbial features—with molecular tumor classification to identify distinct colorectal cancer ecological states. - This metabolic stratification could reveal host-tumor dependencies and therapeutic vulnerabilities that are obscured by current tumor-centric classifications. - The article is a conceptual review; specific experimental methods, dosing, cohort sizes, or quantitative trial results were not reported in the abstract. - Keywords listed by the author include **Colorectal cancer**, **Gut microbiota**, **Immunometabolism**, **Obesity**, **Tumor ecology**, and **Type 2 diabetes**.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43043549/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43043549/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43043549/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43043549/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43043549/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43043549/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43043549/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043549/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043549/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43043549/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043549/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43043549/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43043549/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43043549/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43043549/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43043549/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43043549/#mesh-terms) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Review Cancer Metastasis Rev Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer+Metastasis+Rev%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer+Metastasis+Rev%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) . 2026 Nov 17;45(4):89. doi: 10.1007/s10555-026-10399-y. # Metabolic disease engineers the colorectal cancer ecosystem [Alejandro Schcolnik-Cabrera](https://pubmed.ncbi.nlm.nih.gov/?term=Schcolnik-Cabrera+A&cauthor_id=43043549)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043549/#full-view-affiliation-1 "Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada. schcolni@ualberta.ca.") Affiliations Expand ### Affiliation * 1 Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada. schcolni@ualberta.ca. * PMID: **43043549** * DOI: [ 10.1007/s10555-026-10399-y ](https://doi.org/10.1007/s10555-026-10399-y) Item in Clipboard Review # Metabolic disease engineers the colorectal cancer ecosystem Alejandro Schcolnik-Cabrera. Cancer Metastasis Rev. 2026. Show details Display options Display options Format Abstract PubMed PMID Cancer Metastasis Rev Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer+Metastasis+Rev%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer+Metastasis+Rev%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) . 2026 Nov 17;45(4):89. doi: 10.1007/s10555-026-10399-y. ### Author [Alejandro Schcolnik-Cabrera](https://pubmed.ncbi.nlm.nih.gov/?term=Schcolnik-Cabrera+A&cauthor_id=43043549)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043549/#short-view-affiliation-1 "Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada. schcolni@ualberta.ca.") ### Affiliation * 1 Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada. schcolni@ualberta.ca. * PMID: **43043549** * DOI: [ 10.1007/s10555-026-10399-y ](https://doi.org/10.1007/s10555-026-10399-y) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Obesity and type 2 diabetes (T2D) increase colorectal cancer (CRC) risk, yet the mechanisms linking systemic metabolic dysfunction to carcinogenesis are usually considered independently. I propose that metabolic disease can act as an ecosystem engineer, altering the selective conditions in which neoplastic cells emerge and evolve. Nutrient availability, adipose dysfunction, metabolic-epigenetic coupling, immunometabolic rewiring, microbial remodeling, and bile acid metabolism interact across the colonic environment, redistributing metabolic fitness among epithelial, immune, and microbial populations. These interactions may establish a self-reinforcing ecosystem that favors metabolically adaptable clones and reduces constraints on their persistence. Metabolic dysfunction may thus alter which cellular populations can most effectively exploit available resources and evade antitumor surveillance. This hypothesis predicts that tumors with similar molecular characteristics may exist within biologically distinct environments according to the host metabolic state, and therefore could show differential responses to immune activity and therapy. Integrating systemic metabolic parameters, including adiposity distribution, insulin resistance, glycemic control, circulating metabolites, and microbial features, with molecular tumor classification could reveal distinct CRC ecological states and host-tumor dependencies. Such metabolic stratification could generate opportunities for personalized prevention and therapy by identifying vulnerabilities that remain obscured by current tumor-centric classification. **Keywords:** Colorectal cancer; Gut microbiota; Immunometabolism; Obesity; Tumor ecology; Type 2 diabetes. © 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: The authors declare no competing interests. ## References 1. 1. Collaboration NCDRF. (2024). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 403(10431), 1027–50. 2. 1. Collaboration NCDRF. (2024). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants. Lancet, 404(10467), 2077–93. 3. 1. Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/38572751/) 4. 1. The Lancet Gastroenterology H. (2025). The rise in early-onset colorectal cancer: now a global issue. Lancet Gastroenterol Hepatol, 10(2), 95. 5. 1. Lawler, T., Walts, Z. L., Steinwandel, M., Lipworth, L., Murff, H. J., Zheng, W., et al. (2023). Type 2 diabetes and colorectal cancer risk. JAMA Network Open, 6(11), e2343333. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/37962884/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/10646729/) - [DOI](https://doi.org/10.1001/jamanetworkopen.2023.43333) Show all 70 references ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Colorectal Neoplasms* / etiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fetiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Colorectal Neoplasms* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Colorectal Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Diabetes Mellitus, Type 2* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Diabetes Mellitus, Type 2* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Metabolic Diseases* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Diseases%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Metabolic Diseases* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Diseases%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Metabolic Reprogramming Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Reprogramming%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Reprogramming) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Obesity / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Obesity%2Fcomplications%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Obesity) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Obesity / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Obesity%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Obesity) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) * Tumor Microenvironment Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Tumor+Microenvironment%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Tumor+Microenvironment) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043549/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43043549/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43043549/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043549%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43043549/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.hhs.gov/) * [USA.gov](https://www.usa.gov/)
## Related Clinical Research

- [Obesity-associated inflammation and cancer: mechanisms linking adipose immune changes to tumor risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-obesity-associated-inflammation-and-cancer-molecular-mechanisms-evidence-gaps.md)
- [Weight loss drugs slash risk of 4 types of cancer by 50% or more, study finds](https://medichelpline.com/clinical-feed/medical-news-today-23-weight-loss-drugs-slash-risk-of-4-types-of-cancer-by-50-or-more-study-finds.md)
- [Moringa oleifera composition and mechanisms related to obesity, type 2 diabetes, and cancer](https://medichelpline.com/clinical-feed/pubmed-42680270.md) (DOI: 10.1016/j.foodres.2026.119925)
- [GLP-1 receptor agonist weight loss in breast cancer patients on endocrine therapy](https://medichelpline.com/clinical-feed/pubmed-42932003.md) (DOI: 10.1007/s10549-026-08096-z)
- [Inflammatory Biomarkers and Risk of Postmenopausal ER-Positive Breast Cancer](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-inflammatory-biomarkers-and-risk-of-postmenopausal-oestrogen-receptor-positive.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.